Liabilities / Assets
93rd percentile
Higher debt load relative to assets than 93% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.87x
Liabilities / Revenue
93rd percentile
Higher debt load relative to revenue than 93% of similar nonprofits.
Net Margin
5th percentile
Higher net margin than 5% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
14th percentile
Faster asset growth than 14% of similar nonprofits.
Revenue Growth
7th percentile
Faster revenue growth than 7% of similar nonprofits.
Balance Sheet
Assets
Down$266,373
Down $138,028 (-34%) from 2018
Net Assets
Down$33,840
Down $354,129 (-91%) from 2018
Liabilities
Up$232,533
Up $216,101 (+1315%) from 2018
Revenue And Expenses
Revenue
Down$421,287
Down $711,058 (-63%) from 2018
Expenses
Down$775,416
Down $100,310 (-11%) from 2018
Net Income
Down-$354,129
Down $610,748 (-238%) from 2018
Historical Trend
Filing Detail Status
This 2019 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2019 to Dec 31, 2019
Mission and Program Overview
Mission
Supports organizations and initiatives that improve the availability of vaccines, medicines and other healthcare products to those in need worldwide through a variety of educational and charitable activities, including those focused on pharmaceutical supply chain improvements.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2019 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $266,373
- Liabilities
- $232,533
- Net assets
- $33,840
- Revenue
- $421,287
- Expenses
- $775,416
- Net income
- -$354,129